Trajectories of brain loss in aging and the development of cognitive impairment - PubMed (original) (raw)
Comparative Study
. 2008 Mar 11;70(11):828-33.
doi: 10.1212/01.wnl.0000280577.43413.d9. Epub 2007 Nov 28.
Affiliations
- PMID: 18046010
- DOI: 10.1212/01.wnl.0000280577.43413.d9
Comparative Study
Trajectories of brain loss in aging and the development of cognitive impairment
N E Carlson et al. Neurology. 2008.
Abstract
Background: The use of volumetric MRI as a biomarker for assessing transitions to dementia presumes that more rapid brain loss marks the clinical transition from benign aging to mild cognitive impairment (MCI). The trajectory of this volume loss relative to the timing of the clinical transition to dementia has not been established.
Methods: The authors annually evaluated 79 healthy elderly subjects for up to 15 consecutive years with standardized clinical examinations and volumetric brain MRI assessments of ventricular volume. During the study period, 37 subjects developed MCI. A mixed effects model with a change point modeled the pattern of brain volume loss in healthy aging compared with subjects diagnosed with MCI.
Results: The brain loss trajectory of subjects developing MCI during follow-up differed from healthy aging in a two-phase process. First, the annual rate of expansion of ventricular volume decreased with age; however, the annual rates of expansion were greater in those who developed cognitive impairment during follow-up compared with those who did not. Further, subjects who developed MCI had an acceleration of ventricular volume expansion approximately 2.3 years prior to clinical diagnosis of MCI.
Conclusions: Ventricular expansion is faster in those developing mild cognitive impairment years prior to clinical symptoms, and eventually a more rapid expansion occurs approximately 24 months prior to the emergence of clinical symptoms. These differential rates of preclinical atrophy suggest that there are specific windows for optimal timing of introduction of dementia prevention therapies in the future.
Comment in
- Expanding ventricles may detect preclinical Alzheimer disease.
Weiner MW. Weiner MW. Neurology. 2008 Mar 11;70(11):824-5. doi: 10.1212/01.wnl.0000304743.72127.cc. Neurology. 2008. PMID: 18332339 Free PMC article. No abstract available. - Trajectories of brain loss in aging and the development of cognitive impairment.
Carmichael OT, Lopez O, Becker JT, Kuller L. Carmichael OT, et al. Neurology. 2009 Feb 24;72(8):771; author reply 771-2. doi: 10.1212/01.wnl.0000339386.26096.93. Neurology. 2009. PMID: 19237712 No abstract available.
Similar articles
- MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS, Huang J, Chowdhury MH. Meyer JS, et al. J Neurol Sci. 2007 Jun 15;257(1-2):97-104. doi: 10.1016/j.jns.2007.01.016. Epub 2007 Feb 21. J Neurol Sci. 2007. PMID: 17316690 - Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.
Driscoll I, Davatzikos C, An Y, Wu X, Shen D, Kraut M, Resnick SM. Driscoll I, et al. Neurology. 2009 Jun 2;72(22):1906-13. doi: 10.1212/WNL.0b013e3181a82634. Neurology. 2009. PMID: 19487648 Free PMC article. - Trajectory of mild cognitive impairment onset.
Howieson DB, Carlson NE, Moore MM, Wasserman D, Abendroth CD, Payne-Murphy J, Kaye JA. Howieson DB, et al. J Int Neuropsychol Soc. 2008 Mar;14(2):192-8. doi: 10.1017/S1355617708080375. J Int Neuropsychol Soc. 2008. PMID: 18282317 - Computational anatomical methods as applied to ageing and dementia.
Thompson PM, Apostolova LG. Thompson PM, et al. Br J Radiol. 2007 Dec;80 Spec No 2:S78-91. doi: 10.1259/BJR/20005470. Br J Radiol. 2007. PMID: 18445748 Review. - Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease?
Smith G. Smith G. J Neural Transm Suppl. 2002;(62):97-104. doi: 10.1007/978-3-7091-6139-5_10. J Neural Transm Suppl. 2002. PMID: 12456055 Review.
Cited by
- Biomarkers predicting Alzheimer's disease in cognitively normal aging.
Shim YS, Morris JC. Shim YS, et al. J Clin Neurol. 2011 Jun;7(2):60-8. doi: 10.3988/jcn.2011.7.2.60. Epub 2011 Jun 28. J Clin Neurol. 2011. PMID: 21779293 Free PMC article. - Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.
Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, Mielke MM, Roberts RO, Gunter JL, Senjem ML, Geda YE, Rocca WA, Petersen RC, Jack CR Jr. Vemuri P, et al. Neurology. 2016 Mar 22;86(12):1128-35. doi: 10.1212/WNL.0000000000002490. Epub 2016 Feb 24. Neurology. 2016. PMID: 26911640 Free PMC article. - Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.
Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Lowe V, Kantarci K, Bernstein MA, Senjem ML, Gunter JL, Boeve BF, Trojanowski JQ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Knopman DS; Alzheimer’s Disease Neuroimaging Initiative. Jack CR Jr, et al. Arch Neurol. 2012 Jul;69(7):856-67. doi: 10.1001/archneurol.2011.3405. Arch Neurol. 2012. PMID: 22409939 Free PMC article. - Progression of atrophy in Alzheimer's disease and related disorders.
Whitwell JL. Whitwell JL. Neurotox Res. 2010 Nov;18(3-4):339-46. doi: 10.1007/s12640-010-9175-1. Epub 2010 Mar 30. Neurotox Res. 2010. PMID: 20352396 Review. - Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Stonnington CM, Chen Y, Savage CR, Lee W, Bauer RJ III, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, Reiman EM, Chen K. Stonnington CM, et al. J Alzheimers Dis. 2018;63(2):603-615. doi: 10.3233/JAD-170852. J Alzheimers Dis. 2018. PMID: 29630550 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical